(Q38100815)

28 August 2017

Antiobesity carbonic anhydrase inhibitors: a literature and patent review (English)

1 reference

28 August 2017

1

1 reference

28 August 2017

Fabrizio Carta

3

0 references

Claudiu T Supuran

series ordinal

2

object named as

Claudiu T Supuran

1 reference

PubMed ID

23607332

28 August 2017

language of work or name

English

0 references

publication date

22 April 2013

1 reference

Expert Opinion on Therapeutic Patents

28 August 2017

1 reference

28 August 2017

23

1 reference

28 August 2017

6

1 reference

28 August 2017

725-735

1 reference

A randomized trial of sugar-sweetened beverages and adolescent body weight

28 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Safety of drug therapies used for weight loss and treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Obesity drug pipeline not so fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Role of cholecystokinin in appetite control and body weight regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

The role of ghrelin in the control of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Anti-obesity drugs: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Ghrelin levels in young children with Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Elevated plasma ghrelin levels in Prader–Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Leptin at 14 y of age: an ongoing story

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Effects of recombinant leptin therapy in a child with congenital leptin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Partial leptin deficiency and human adiposity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Central nervous system control of food intake and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Sibutramine. A review of its contribution to the management of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Drug treatments for obesity: orlistat, sibutramine, and rimonabant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Structure-based drug discovery of carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Human mitochondrial carbonic anhydrase VB. cDNA cloning, mRNA expression, subcellular localization, and mapping to chromosome x

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Mitochondrial carbonic anhydrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Carbonic anhydrase isozymes in the human pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Mitochondrial carbonic anhydrase CA VB: differences in tissue distribution and pattern of evolution from those of CA VA suggest distinct physiological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Mood stabilization and weight loss with topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Role of hepatic carbonic anhydrase in de novo lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Molecular modeling study for the binding of zonisamide and topiramate to the human mitochondrial carbonic anhydrase isoform VA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

What is the prognosis for new centrally-acting anti-obesity drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Zonisamide: review of its use in epilepsy therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Mechanism of mitochondrial uncouplers, inhibitors, and toxins: focus on electron transfer, free radicals, and structure-activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Carbonic anhydrase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

The first example of a significant active site conformational rearrangement in a carbonic anhydrase-inhibitor adduct: the carbonic anhydrase I-topiramate complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

Inhibition of human mitochondrial carbonic anhydrases VA and VB with para-(4-phenyltriazole-1-yl)-benzenesulfonamide derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.790957

10.1517/13543776.2013.790957

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference

PubMed ID

23607332